AstraZeneca India invests ₹250 crore to expand Chennai's GITC, creating 1,300 jobs and leveraging AI, ML, and analytics.
AstraZeneca India Private Limited (AZIPL) will invest Rs 250 crore to expand its Global Innovation and Technology Centre (GITC) in Chennai, adding around 1,300 job roles focused on driving innovation, enhancing efficiency, and streamlining operations across the company globally. The investment marks a significant milestone in AstraZeneca's growth story in India, as it celebrates its 45th year in the country this month. The expanded GITC will leverage technologies such as enterprise platforms, artificial intelligence, machine learning, data science, and supply chain analytics to shape healthcare outcomes.
July 04, 2024
4 Articles